{
    "root": "ebbb6769-54f5-415e-a685-0c6baf35645d",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "terbinafine hydrochloride",
    "value": "20250203",
    "ingredients": [
        {
            "name": "TERBINAFINE HYDROCHLORIDE",
            "code": "012C11ZU6G"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "HYPROMELLOSE 2910 (5 MPA.S)",
            "code": "R75537T0T4"
        }
    ],
    "indications": "terbinafine tablets indicated treatment onychomycosis toenail fingernail due dermatophytes ( tinea unguium ) . prior initiating treatment , appropriate nail specimens laboratory testing [ potassium hydroxide ( koh ) preparation , fungal culture , nail biopsy ] obtained confirm diagnosis onychomycosis .",
    "contraindications": "prior administering , evaluate patients evidence chronic active liver disease . ( 2.1 ) fingernail onychomycosis : one tablet , daily 6 weeks . ( 2.2 ) toenail onychomycosis : one tablet , daily 12 weeks . ( 2.2 )",
    "warningsAndPrecautions": "terbinafine tablets usp , 250 mg supplied light pink mottled surface , round , bi-convex , tablets debossed \u201c 501 \u201d one side plain side . ndc 71335-9677-1 : 30 tablets bottle ndc 71335-9677-2 : 60 tablets bottle ndc 71335-9677-3 : 90 tablets bottle ndc 71335-9677-4 : 100 tablets bottle ndc 71335-9677-5 : 7 tablets bottle ndc 71335-9677-6 : 40 tablets bottle ndc 71335-9677-7 : 45 tablets bottle ndc 71335-9677-8 : 14 tablets bottle ndc 71335-9677-9 : 28 tablets bottle store terbinafine tablets 20\u00b0 25\u00b0c ( 68\u00b0 77 \u00b0f ) [ usp controlled room temperature ] ; tight container . protect light . repackaged/relabeled : bryant ranch prepack , inc.burbank , ca 91504",
    "adverseReactions": "terbinafine tablets contraindicated patients : chronic active liver disease [ ( 5.1 ) ] history allergic reaction oral terbinafine risk anaphylaxis [ ( 6.2 ) ]",
    "indications_original": "Terbinafine tablets are indicated for the treatment of onychomycosis of the toenail or fingernail due to dermatophytes (tinea unguium).\n                  Prior to initiating treatment, appropriate nail specimens for laboratory testing [potassium hydroxide (KOH) preparation, fungal culture, or nail biopsy] should be obtained to confirm the diagnosis of onychomycosis.",
    "contraindications_original": "Prior to administering, evaluate patients for evidence of chronic or active liver disease. (2.1) Fingernail onychomycosis: One tablet, once daily for 6 weeks. (2.2) Toenail onychomycosis: One tablet, once daily for 12 weeks. (2.2)",
    "warningsAndPrecautions_original": "Terbinafine tablets USP, 250 mg are supplied as light pink with mottled surface, round, bi-convex, tablets debossed with \u201c501\u201d on one side and plain on the other side.\n                  \n                     NDC 71335-9677-1: 30 Tablets in a BOTTLE\n                     NDC 71335-9677-2: 60 Tablets in a BOTTLE\n                     NDC 71335-9677-3: 90 Tablets in a BOTTLE\n                     NDC 71335-9677-4: 100 Tablets in a BOTTLE\n                     NDC 71335-9677-5: 7 Tablets in a BOTTLE\n                     NDC 71335-9677-6: 40 Tablets in a BOTTLE\n                     NDC 71335-9677-7: 45 Tablets in a BOTTLE\n                     NDC 71335-9677-8: 14 Tablets in a BOTTLE\n                     NDC 71335-9677-9: 28 Tablets in a BOTTLE\n                  \n                  Store terbinafine tablets at 20\u00b0 to 25\u00b0C (68\u00b0 to 77 \u00b0F) [see USP Controlled Room Temperature]; in a tight container. Protect from light.\n                  Repackaged/Relabeled by:Bryant Ranch Prepack, Inc.Burbank, CA 91504",
    "adverseReactions_original": "Terbinafine tablets are contraindicated in patients with:\n                  \n                     Chronic or active liver disease [see Warnings and Precautions (5.1)]\n                     History of allergic reaction to oral terbinafine because of the risk of anaphylaxis [see Adverse Reactions (6.2)]"
}